At dawn in Kumasi's crowded Sawaba neighbourhood, 67-year-old Kofi Owusu Mensah begins his day facing a painful and familiar dilemma: buy food for his family or insulin for himself.

Tandem Diabetes Care has announced that the Tandem t:slimX2 insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott’s FreeStyle Libre 3 Plus continuous glucose ...

One of the first brain cells shown to make insulin is the neurogliaform cell. These live in a brain area important for ...

Sana is Incorporating the Tested Immune Evasion Technology to Develop SC451, a HIP-modified, Stem Cell-Derived Therapy as a One-Time Treatment for Patients with Type 1 Diabetes, with a Goal of Normal ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the ...

Multiple developers of connected diabetes hardware have announced plans this week to link their insulin pumps with continuous ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...

Potential biosimilar impact Outside of Congress, there is another element that could reduce the cost of insulin, in the form of biosimilars. Due to a change in the classification of insulin ...

Today, we recommend two stocks, one from the healthcare sector and another from the railways sector, recommended by the Trade ...